Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

Reference intervals of nine steroid hormones over the life-span analyzed by LC-MS/MS: Effect of age, gender, puberty, and oral contraceptives.

Bae YJ, Zeidler R, Baber R, Vogel M, Wirkner K, Loeffler M, Ceglarek U, Kiess W, Körner A, Thiery J, Kratzsch J.

J Steroid Biochem Mol Biol. 2019 Jun 12;193:105409. doi: 10.1016/j.jsbmb.2019.105409. [Epub ahead of print]

PMID:
31201927
2.

Intracavitary radioimmunotherapy of high-grade gliomas: present status and future developments.

Reulen HJ, Suero Molina E, Zeidler R, Gildehaus FJ, Böning G, Gosewisch A, Stummer W.

Acta Neurochir (Wien). 2019 Jun;161(6):1109-1124. doi: 10.1007/s00701-019-03882-9. Epub 2019 Apr 12. Review.

PMID:
30980242
3.

Engineering extracellular vesicles as novel treatment options: exploiting herpesviral immunity in CLL.

Gärtner K, Luckner M, Wanner G, Zeidler R.

J Extracell Vesicles. 2019 Feb 11;8(1):1573051. doi: 10.1080/20013078.2019.1573051. eCollection 2019.

4.

Spatiotemporally Skewed Activation of Programmed Cell Death Receptor 1-Positive T Cells after Epstein-Barr Virus Infection and Tumor Development in Long-Term Fully Humanized Mice.

Danisch S, Slabik C, Cornelius A, Albanese M, Tagawa T, Chen YA, Krönke N, Eiz-Vesper B, Lienenklaus S, Bleich A, Theobald SJ, Schneider A, Ganser A, von Kaisenberg C, Zeidler R, Hammerschmidt W, Feuerhake F, Stripecke R.

Am J Pathol. 2019 Mar;189(3):521-539. doi: 10.1016/j.ajpath.2018.11.014. Epub 2018 Dec 26.

5.

Novel fluorinated carbonic anhydrase IX inhibitors reduce hypoxia-induced acidification and clonogenic survival of cancer cells.

Kazokaitė J, Niemans R, Dudutienė V, Becker HM, Leitāns J, Zubrienė A, Baranauskienė L, Gondi G, Zeidler R, Matulienė J, Tārs K, Yaromina A, Lambin P, Dubois LJ, Matulis D.

Oncotarget. 2018 Jun 1;9(42):26800-26816. doi: 10.18632/oncotarget.25508. eCollection 2018 Jun 1.

6.

An inhibitory antibody targeting carbonic anhydrase XII abrogates chemoresistance and significantly reduces lung metastases in an orthotopic breast cancer model in vivo.

von Neubeck B, Gondi G, Riganti C, Pan C, Parra Damas A, Scherb H, Ertürk A, Zeidler R.

Int J Cancer. 2018 Oct 15;143(8):2065-2075. doi: 10.1002/ijc.31607. Epub 2018 Aug 10.

7.

Fully Automated Production and Characterization of 64 Cu and Proof-of-Principle Small-Animal PET Imaging Using 64 Cu-Labelled CA XII Targeting 6A10 Fab.

Fiedler L, Kellner M, Oos R, Böning G, Ziegler S, Bartenstein P, Zeidler R, Gildehaus FJ, Lindner S.

ChemMedChem. 2018 Jun 20;13(12):1230-1237. doi: 10.1002/cmdc.201800130. Epub 2018 May 23.

PMID:
29667369
8.

Tumor-derived extracellular vesicles activate primary monocytes.

Gärtner K, Battke C, Dünzkofer J, Hüls C, von Neubeck B, Kellner MK, Fiestas E, Fackler S, Lang S, Zeidler R.

Cancer Med. 2018 May;7(5):2013-2020. doi: 10.1002/cam4.1465. Epub 2018 Mar 30.

9.

Evaluation of 177Lu[Lu]-CHX-A″-DTPA-6A10 Fab as a radioimmunotherapy agent targeting carbonic anhydrase XII.

Fiedler L, Kellner M, Gosewisch A, Oos R, Böning G, Lindner S, Albert N, Bartenstein P, Reulen HJ, Zeidler R, Gildehaus FJ.

Nucl Med Biol. 2018 May;60:55-62. doi: 10.1016/j.nucmedbio.2018.02.004. Epub 2018 Mar 4.

PMID:
29571067
10.

[Standards for treatment in forensic committment according to § 63 and § 64 of the German criminal code : Interdisciplinary task force of the DGPPN].

Müller JL, Saimeh N, Briken P, Eucker S, Hoffmann K, Koller M, Wolf T, Dudeck M, Hartl C, Jakovljevic AK, Klein V, Knecht G, Müller-Isberner R, Muysers J, Schiltz K, Seifert D, Simon A, Steinböck H, Stuckmann W, Weissbeck W, Wiesemann C, Zeidler R.

Nervenarzt. 2017 Aug;88(Suppl 1):1-29. doi: 10.1007/s00115-017-0382-3. Review. German.

PMID:
28776213
11.

Molecular epigenetic targets for liver diseases: current challenges and future prospects.

Zeidler R, de Freitas Soares BL, Bader A, Giri S.

Drug Discov Today. 2017 Nov;22(11):1620-1636. doi: 10.1016/j.drudis.2017.07.008. Epub 2017 Jul 25. Review.

PMID:
28754290
12.

[DGPPN recommendations on quality indicators for schizophrenia].

Großimlinghaus I, Hauth I, Falkai P, Janssen B, Deister A, Meyer-Lindenberg A, Roth-Sackenheim C, Schneider F, Wobrock T, Zeidler R, Gaebel W.

Nervenarzt. 2017 Jul;88(7):779-786. doi: 10.1007/s00115-017-0347-6. German.

PMID:
28484822
13.

Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells.

Rancan C, Schirrmann L, Hüls C, Zeidler R, Moosmann A.

PLoS Pathog. 2015 Jun 11;11(6):e1004906. doi: 10.1371/journal.ppat.1004906. eCollection 2015 Jun.

14.

Esterase activity of carbonic anhydrases serves as surrogate for selecting antibodies blocking hydratase activity.

Uda NR, Seibert V, Stenner-Liewen F, Müller P, Herzig P, Gondi G, Zeidler R, van Dijk M, Zippelius A, Renner C.

J Enzyme Inhib Med Chem. 2015 Dec;30(6):955-60. doi: 10.3109/14756366.2014.1001754. Epub 2015 Sep 4.

PMID:
25775095
15.

EVpedia: a community web portal for extracellular vesicles research.

Kim DK, Lee J, Kim SR, Choi DS, Yoon YJ, Kim JH, Go G, Nhung D, Hong K, Jang SC, Kim SH, Park KS, Kim OY, Park HT, Seo JH, Aikawa E, Baj-Krzyworzeka M, van Balkom BW, Belting M, Blanc L, Bond V, Bongiovanni A, Borràs FE, Buée L, Buzás EI, Cheng L, Clayton A, Cocucci E, Dela Cruz CS, Desiderio DM, Di Vizio D, Ekström K, Falcon-Perez JM, Gardiner C, Giebel B, Greening DW, Gross JC, Gupta D, Hendrix A, Hill AF, Hill MM, Nolte-'t Hoen E, Hwang DW, Inal J, Jagannadham MV, Jayachandran M, Jee YK, Jørgensen M, Kim KP, Kim YK, Kislinger T, Lässer C, Lee DS, Lee H, van Leeuwen J, Lener T, Liu ML, Lötvall J, Marcilla A, Mathivanan S, Möller A, Morhayim J, Mullier F, Nazarenko I, Nieuwland R, Nunes DN, Pang K, Park J, Patel T, Pocsfalvi G, Del Portillo H, Putz U, Ramirez MI, Rodrigues ML, Roh TY, Royo F, Sahoo S, Schiffelers R, Sharma S, Siljander P, Simpson RJ, Soekmadji C, Stahl P, Stensballe A, Stępień E, Tahara H, Trummer A, Valadi H, Vella LJ, Wai SN, Witwer K, Yáñez-Mó M, Youn H, Zeidler R, Gho YS.

Bioinformatics. 2015 Mar 15;31(6):933-9. doi: 10.1093/bioinformatics/btu741. Epub 2014 Nov 10.

16.

The role of tumour FoxP3 as prognostic marker in different subtypes of head and neck cancer.

Weller P, Bankfalvi A, Gu X, Dominas N, Lehnerdt GF, Zeidler R, Lang S, Brandau S, Dumitru CA.

Eur J Cancer. 2014 May;50(7):1291-300. doi: 10.1016/j.ejca.2014.02.016. Epub 2014 Mar 11.

PMID:
24630394
17.

Antitumor efficacy of a monoclonal antibody that inhibits the activity of cancer-associated carbonic anhydrase XII.

Gondi G, Mysliwietz J, Hulikova A, Jen JP, Swietach P, Kremmer E, Zeidler R.

Cancer Res. 2013 Nov 1;73(21):6494-503. doi: 10.1158/0008-5472.CAN-13-1110. Epub 2013 Sep 12.

18.

Neutrophils Activate Tumoral CORTACTIN to Enhance Progression of Orohypopharynx Carcinoma.

Dumitru CA, Bankfalvi A, Gu X, Eberhardt WE, Zeidler R, Lang S, Brandau S.

Front Immunol. 2013 Feb 18;4:33. doi: 10.3389/fimmu.2013.00033. eCollection 2013.

19.

AHNAK and inflammatory markers predict poor survival in laryngeal carcinoma.

Dumitru CA, Bankfalvi A, Gu X, Zeidler R, Brandau S, Lang S.

PLoS One. 2013;8(2):e56420. doi: 10.1371/journal.pone.0056420. Epub 2013 Feb 7.

20.

HIV Nef, paxillin, and Pak1/2 regulate activation and secretion of TACE/ADAM10 proteases.

Lee JH, Wittki S, Bräu T, Dreyer FS, Krätzel K, Dindorf J, Johnston IC, Gross S, Kremmer E, Zeidler R, Schlötzer-Schrehardt U, Lichtenheld M, Saksela K, Harrer T, Schuler G, Federico M, Baur AS.

Mol Cell. 2013 Feb 21;49(4):668-79. doi: 10.1016/j.molcel.2012.12.004. Epub 2013 Jan 11.

21.

Murine gammaherpesvirus 68 glycoprotein 150 does not contribute to latency amplification in vivo.

Ruiss R, Ohno S, Steer B, Zeidler R, Adler H.

Virol J. 2012 Jun 9;9:107. doi: 10.1186/1743-422X-9-107.

22.

The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination.

Jochum S, Moosmann A, Lang S, Hammerschmidt W, Zeidler R.

PLoS Pathog. 2012;8(5):e1002704. doi: 10.1371/journal.ppat.1002704. Epub 2012 May 17.

23.

RNAs in Epstein-Barr virions control early steps of infection.

Jochum S, Ruiss R, Moosmann A, Hammerschmidt W, Zeidler R.

Proc Natl Acad Sci U S A. 2012 May 22;109(21):E1396-404. doi: 10.1073/pnas.1115906109. Epub 2012 Apr 27.

24.

EBV-gp350 confers B-cell tropism to tailored exosomes and is a neo-antigen in normal and malignant B cells--a new option for the treatment of B-CLL.

Ruiss R, Jochum S, Mocikat R, Hammerschmidt W, Zeidler R.

PLoS One. 2011;6(10):e25294. doi: 10.1371/journal.pone.0025294. Epub 2011 Oct 10.

25.

A virus-like particle-based Epstein-Barr virus vaccine.

Ruiss R, Jochum S, Wanner G, Reisbach G, Hammerschmidt W, Zeidler R.

J Virol. 2011 Dec;85(24):13105-13. doi: 10.1128/JVI.05598-11. Epub 2011 Oct 12.

26.

Biodistribution of 131I-labeled anti-CK8 monoclonal antibody in HNSCC in xenotransplanted SCID mice.

Andratschke M, Luebbers CW, Johannson V, Schmitt B, Mack B, Zeidler R, Lang S, Wollenberg B, Gildehaus FJ.

Anticancer Res. 2011 Oct;31(10):3315-21.

PMID:
21965741
27.

[Innovations in biomarker development: a pathway towards individualized cancer therapy?].

Dumitru CA, Hoffmann TK, Lehnerdt G, Zeidler R, Lang S, Brandau S.

Laryngorhinootologie. 2011 Mar;90(3):168-77. doi: 10.1055/s-0030-1270472. Epub 2011 Mar 4. Review. German.

PMID:
21380962
28.

Generation and characterization of the first inhibitory antibody targeting tumour-associated carbonic anhydrase XII.

Battke C, Kremmer E, Mysliwietz J, Gondi G, Dumitru C, Brandau S, Lang S, Vullo D, Supuran C, Zeidler R.

Cancer Immunol Immunother. 2011 May;60(5):649-58. doi: 10.1007/s00262-011-0980-z. Epub 2011 Feb 5.

PMID:
21298264
29.

Tumour exosomes inhibit binding of tumour-reactive antibodies to tumour cells and reduce ADCC.

Battke C, Ruiss R, Welsch U, Wimberger P, Lang S, Jochum S, Zeidler R.

Cancer Immunol Immunother. 2011 May;60(5):639-48. doi: 10.1007/s00262-011-0979-5. Epub 2011 Feb 4.

PMID:
21293856
30.

[Diagnostic and prognostic biomarkers in head and neck squamous cell carcinoma].

Lehnerdt G, Hoffmann TK, Mattheis S, Brandau S, Zeidler R, Lang S.

HNO. 2010 Jul;58(7):713-23; quiz 724-5. doi: 10.1007/s00106-010-2108-8. German.

PMID:
20544170
31.

Tumor-derived microvesicles in sera of patients with head and neck cancer and their role in tumor progression.

Bergmann C, Strauss L, Wieckowski E, Czystowska M, Albers A, Wang Y, Zeidler R, Lang S, Whiteside TL.

Head Neck. 2009 Mar;31(3):371-80. doi: 10.1002/hed.20968.

32.

Conditional immortalization of human B cells by CD40 ligation.

Wiesner M, Zentz C, Mayr C, Wimmer R, Hammerschmidt W, Zeidler R, Moosmann A.

PLoS One. 2008 Jan 23;3(1):e1464. doi: 10.1371/journal.pone.0001464.

33.

Molecular profiling for the identification of new biomarkers in smokers and cancer patients.

Albermann K, Lang S, Zeidler R.

Cancer Genomics Proteomics. 2007 Sep-Oct;4(5):349-58. Review.

34.
35.

Nicotine and apoptosis.

Zeidler R, Albermann K, Lang S.

Apoptosis. 2007 Nov;12(11):1927-43. Review.

PMID:
17846896
36.

Immune restoration in head and neck cancer patients after in vivo COX-2 inhibition.

Lang S, Tiwari S, Andratschke M, Loehr I, Lauffer L, Bergmann C, Mack B, Lebeau A, Moosmann A, Whiteside TL, Zeidler R.

Cancer Immunol Immunother. 2007 Oct;56(10):1645-52. Epub 2007 Mar 27.

PMID:
17387473
37.

Biodistribution and radioimmunotherapy of SCCHN in xenotransplantated SCID mice with a 131I-labelled anti-EpCAM monoclonal antibody.

Andratschke M, Gildehaus FJ, Johannson V, Schmitt B, Mack B, Reisbach G, Lang S, Lindhofer H, Zeidler R, Wollenberg B, Luebbers CW.

Anticancer Res. 2007 Jan-Feb;27(1A):431-6.

38.

Activated B cells mediate efficient expansion of rare antigen-specific T cells.

Zentz C, Wiesner M, Man S, Frankenberger B, Wollenberg B, Hillemanns P, Zeidler R, Hammerschmidt W, Moosmann A.

Hum Immunol. 2007 Feb;68(2):75-85. Epub 2007 Jan 8.

PMID:
17321896
39.

Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironment.

Bergmann C, Strauss L, Zeidler R, Lang S, Whiteside TL.

Cancer Immunol Immunother. 2007 Sep;56(9):1429-42. Epub 2007 Jan 31.

PMID:
17265021
40.

Carcinoma-associated eIF3i overexpression facilitates mTOR-dependent growth transformation.

Ahlemann M, Zeidler R, Lang S, Mack B, Münz M, Gires O.

Mol Carcinog. 2006 Dec;45(12):957-67.

PMID:
16929481
41.

Innovative modular membrane adsorber system for high-throughput downstream screening for protein purification.

Kökpinar O, Harkensee D, Kasper C, Scheper T, Zeidler R, Reif OW, Ulber R.

Biotechnol Prog. 2006 Jul-Aug;22(4):1215-9.

PMID:
16889401
42.

COX-inhibitors relieve the immunosuppressive effect of tumor cells and improve functions of immune effectors.

Lang S, Picu A, Hofmann T, Andratschke M, Mack B, Moosmann A, Gires O, Tiwari S, Zeidler R.

Int J Immunopathol Pharmacol. 2006 Apr-Jun;19(2):409-19.

PMID:
16831307
43.

Evaluation of CK8-specific autoantibodies in carcinomas of distinct localisations.

Ahlemann M, Schmitt B, Stieber P, Gires O, Lang S, Zeidler R.

Anticancer Res. 2006 Jan-Feb;26(1B):783-9.

44.
45.

Limited suitability of EpCAM for molecular staging of tumor borders in head and neck cancer.

Andratschke M, Hagedorn H, Luebbers CW, Schmitt B, Lang S, Zeidler R, Wollenberg B.

Anticancer Res. 2006 Jan-Feb;26(1A):153-8.

46.

Genetic design of an optimized packaging cell line for gene vectors transducing human B cells.

Hettich E, Janz A, Zeidler R, Pich D, Hellebrand E, Weissflog B, Moosmann A, Hammerschmidt W.

Gene Ther. 2006 May;13(10):844-56.

PMID:
16421600
47.

Prednisolone reduces TNF-alpha release by PBMCs activated with a trifunctional bispecific antibody but not their anti-tumor activity.

Walz A, Andratschke M, Wollenberg B, Lindhofer H, Zeidler R.

Anticancer Res. 2005 Nov-Dec;25(6B):4239-43.

48.

Fast and efficient protein purification using membrane adsorber systems.

Suck K, Walter J, Menzel F, Tappe A, Kasper C, Naumann C, Zeidler R, Scheper T.

J Biotechnol. 2006 Feb 10;121(3):361-7. Epub 2005 Sep 12.

PMID:
16159680
49.

Selection of CMV-specific CD8+ and CD4+ T cells by mini-EBV-transformed B cell lines.

Wiesner M, Zentz C, Hammer MH, Cobbold M, Kern F, Kolb HJ, Hammerschmidt W, Zeidler R, Moosmann A.

Eur J Immunol. 2005 Jul;35(7):2110-21.

50.

The tumour-associated antigen EpCAM upregulates the fatty acid binding protein E-FABP.

Münz M, Zeidler R, Gires O.

Cancer Lett. 2005 Jul 8;225(1):151-7. Epub 2004 Dec 28.

PMID:
15922867

Supplemental Content

Loading ...
Support Center